These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 29889271)

  • 21. [Assessment of mental states at risk of psychotic transition: validation of the French version of the CAARMS].
    Krebs MO; Magaud E; Willard D; Elkhazen C; Chauchot F; Gut A; Morvan Y; Bourdel MC; Kazes M
    Encephale; 2014 Dec; 40(6):447-56. PubMed ID: 25127895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning.
    Brodey BB; Girgis RR; Favorov OV; Bearden CE; Woods SW; Addington J; Perkins DO; Walker EF; Cornblatt BA; Brucato G; Purcell SE; Brodey IS; Cadenhead KS
    Schizophr Res; 2019 Jun; 208():390-396. PubMed ID: 30777603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Italian version of the 16-item prodromal questionnaire (iPQ-16): Field-test and psychometric features.
    Lorenzo P; Silvia A; Federica P; Sara G; Ilaria S; Pupo S; Raballo A
    Schizophr Res; 2018 Sep; 199():353-360. PubMed ID: 29571752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosis risk screening with the Prodromal Questionnaire--brief version (PQ-B).
    Loewy RL; Pearson R; Vinogradov S; Bearden CE; Cannon TD
    Schizophr Res; 2011 Jun; 129(1):42-6. PubMed ID: 21511440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
    Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
    Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Item-level endorsement on the Prodromal Questionnaire in a large non-clinical sample.
    Capizzi R; Pierce KM; Olino TM; Ellman LM
    Schizophr Res; 2022 Oct; 248():309-319. PubMed ID: 36155304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prodromal psychosis screening in adolescent psychiatry clinics.
    Loewy RL; Therman S; Manninen M; Huttunen MO; Cannon TD
    Early Interv Psychiatry; 2012 Feb; 6(1):69-75. PubMed ID: 21883972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-rank symptoms and premorbid adjustment in young individuals at increased risk of developing psychosis.
    Morcillo C; Stochl J; Russo DA; Zambrana A; Ratnayake N; Jones PB; Perez J
    Psychopathology; 2015; 48(2):120-6. PubMed ID: 25720419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anomalous self-experiences are strongly associated with negative symptoms in a clinical high-risk for psychosis sample.
    Værnes TG; Røssberg JI; Møller P
    Compr Psychiatry; 2019 Aug; 93():65-72. PubMed ID: 31351243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse outcome analysis in people at clinical high risk for psychosis: results from a 2-year Italian follow-up study.
    Pelizza L; Leuci E; Quattrone E; Azzali S; Pupo S; Paulillo G; Menchetti M; Pellegrini P
    Soc Psychiatry Psychiatr Epidemiol; 2024 Jul; 59(7):1177-1191. PubMed ID: 38091031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between psychotic-like symptoms and neurocognitive performance in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Laajasalo T; Mustonen U; Kalska H; Suvisaari J; Moilanen K; Cannon TD; Huttunen M; Therman S
    Schizophr Res; 2010 Oct; 123(1):77-85. PubMed ID: 20729039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Early Psychosis Screener (EPS): Item development and qualitative validation.
    Brodey BB; Addington J; First MB; Perkins DO; Woods SW; Walker EF; Walsh B; Nieri JM; Nunn MB; Putz J; Brodey IS
    Schizophr Res; 2018 Jul; 197():504-508. PubMed ID: 29254878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early psychosis detection program in Chile: A first step for the South American challenge in psychosis research.
    Gaspar PA; Castillo RI; Maturana A; Villar MJ; Ulloa K; González G; Ibaceta O; Ortiz A; Corral S; Mayol R; De Angel V; Aburto MB; Martínez A; Corcoran CM; Silva H
    Early Interv Psychiatry; 2019 Apr; 13(2):328-334. PubMed ID: 30548415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of at-risk symptoms for psychosis in children and adolescents.
    Schimmelmann BG; Walger P; Schultze-Lutter F
    Can J Psychiatry; 2013 Jan; 58(1):32-40. PubMed ID: 23327754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological deficits in participants at clinical high risk for psychosis recruited from the community: relationships to functioning and clinical symptoms.
    Haining K; Matrunola C; Mitchell L; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    Psychol Med; 2020 Jan; 50(1):77-85. PubMed ID: 30862319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the Clinical High-Risk State a Valid Concept? Retrospective Examination in a First-Episode Psychosis Sample.
    Shah JL; Crawford A; Mustafa SS; Iyer SN; Joober R; Malla AK
    Psychiatr Serv; 2017 Oct; 68(10):1046-1052. PubMed ID: 28617204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis.
    Fusar-Poli P; Spencer T; De Micheli A; Curzi V; Nandha S; McGuire P
    Eur Neuropsychopharmacol; 2020 Oct; 39():111-122. PubMed ID: 32921544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grey-matter abnormalities in clinical high-risk participants for psychosis.
    Zikidi K; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Fracasso A; Uhlhaas PJ
    Schizophr Res; 2020 Dec; 226():120-128. PubMed ID: 31740178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.